STTT | 2023年度优秀编委、优秀审稿人、优秀论文揭晓！

STTT根据2022-2023年学术活跃度和对本刊发展的贡献情况，评选出优秀编委10名，授予“2023 STTT Outstanding Editorial Board Member Award”表彰；根据2022-2023年审稿质量、数量、速度等指标，评选出优秀审稿人10名，授予“2023 STTT Outstanding Reviewer Award”表彰；根据期刊官网和Web of Science数据，综合考量论文质量、影响力、引用情况等方面，从2021-2023年发表的论文中评选出10篇优秀论文，授予“2023 STTT Annual Best Paper Award”表彰。衷心感谢所有编委、专家、同行对STTT发展给予的大力支持与帮助，衷心感谢所有作者的辛勤付出（获奖名单附后）！

“2023 STTT国际生物医学大会”将于11月24-27日在成都举行，届时将在大会开幕式上为获奖编委、审稿人和论文作者代表颁发荣誉证书，热忱欢迎广大科研工作者参会，期待与您共聚蓉城，共襄盛会。

本次大会的详细日程详见三轮通知，大会官网：https://mm.sciconf.cn/cn/minisite/index/19866，大会二维码：

优秀编委（按照姓氏拼音排序）：

优秀审稿人（按照姓氏拼音排序）：

优秀文章（按照发表时间排序）：

01

02

03

04

SARS-CoV-2 crosses the blood–brain barrier accompanied with basement membrane disruption without tight junctions alteration

Signal Transduction and Targeted Therapy 6, Article number: 337 (2021)

Ling Zhang, Li Zhou, Linlin Bao, Jiangning Liu, Hua Zhu, Qi Lv, Ruixue Liu, Wei Chen, Wei Tong, Qiang Wei, Yanfeng Xu, Wei Deng, Hong Gao, Jing Xue, Zhiqi Song, Pin Yu, Yunlin Han, Yu Zhang, Xiuping Sun, Xuan Yu & Chuan Qin 

05

06

Thrombin induces ACSL4-dependent ferroptosis during cerebral ischemia/reperfusion

Signal Transduction and Targeted Therapy 7, Article number: 59 (2022)

Qing-zhang Tuo, Yu Liu, Zheng Xiang, Hong-Fa Yan, Ting Zou, Yang Shu, Xu-long Ding, Jin-jun Zou, Shuo Xu, Fei Tang, Yan-qiu Gong, Xiao-lan Li, Yu-jie Guo, Zhao-yue Zheng, Ai-ping Deng, Zhang-zhong Yang, Wen-jing Li, Shu-ting Zhang, Scott Ayton, Ashley I. Bush, Heng Xu, Lunzhi Dai, Biao Dong & Peng Lei 

07

POD Nanozyme optimized by charge separation engineering for light/pH activated bacteria catalytic/photodynamic therapy

Signal Transduction and Targeted Therapy 7, Article number: 86 (2022)

Changyu Cao, Tingbo Zhang, Nan Yang, Xianghong Niu, Zhaobo Zhou, Jinlan Wang, Dongliang Yang, Peng Chen, Liping Zhong, Xiaochen Dong & Yongxiang Zhao 

08

Tracking SARS-CoV-2 Omicron diverse spike gene mutations identifies multiple inter-variant recombination events

Signal Transduction and Targeted Therapy 7, Article number: 138 (2022)

Junxian Ou, Wendong Lan, Xiaowei Wu, Tie Zhao, Biyan Duan, Peipei Yang, Yi Ren, Lulu Quan, Wei Zhao, Donald Seto, James Chodosh, Zhen Luo, Jianguo Wu & Qiwei Zhang 

09

Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)

Signal Transduction and Targeted Therapy 8, Article number: 58 (2023)

Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, Wei-Zhu Yang, Guo-Wen Yin, Bin-Yan Zhong, Jun-Hui Sun, Zhi-Cheng Jin, Jian-Jian Chen, Nai-Jian Ge, Wen-Bin Ding, Wen-Hui Li, Jin-Hua Huang, Wei Mu, Shan-Zhi Gu, Jia-Ping Li, Hui Zhao, Shu-Wei Wen, Yan-Ming Lei, Yu-Sheng Song, Chun-Wang Yuan, Wei-Dong Wang, Ming Huang, Wei Zhao, Jian-Bing Wu, Song Wang, Xu Zhu, Jian-Jun Han, Wei-Xin Ren, Zai-Ming Lu, Wen-Ge Xing, Yong Fan, Hai-Lan Lin, Zi-Shu Zhang, Guo-Hui Xu, Wen-Hao Hu, Qiang Tu, Hong-Ying Su, Chuan-Sheng Zheng, Yong Chen, Xu-Ya Zhao, Zhu-Ting Fang, Qi Wang, Jin-Wei Zhao, Ai-Bing Xu, Jian Xu, Qing-Hua Wu, Huan-Zhang Niu, Jian Wang, Feng Dai, Dui-Ping Feng, Qing-Dong Li, Rong-Shu Shi, Jia-Rui Li, Guang Yang, Hai-Bin Shi, Jian-Song Ji, Yu-E Liu, Zheng Cai, Po Yang, Yang Zhao, Xiao-Li Zhu, Li-Gong Lu & Gao-Jun Teng for the CHANCE001 Investigators

10

Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 study

Signal Transduction and Targeted Therapy 8, Article number: 106 (2023)

Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan & Jian Zhou